Interestingly, we found that olmutinib, another third-generation EGFR inhibitor, shows no obvious autophagy induction in CRC cells (Supplementary Fig. 3G), again suggesting that OSI-induced autophagy induction might represent an EGFR-independent mechanism. This evidence concerns the gene EGFR and colorectal carcinoma.